List of Locoid drug patents

Locoid is owned by Bausch.

Locoid contains Hydrocortisone Butyrate.

Locoid has a total of 2 drug patents out of which 0 drug patents have expired.

Locoid was authorised for market use on 18 May, 2007.

Locoid is available in lotion;topical dosage forms.

The generics of Locoid are possible to be released after 19 December, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7981877 BAUSCH Stabilized steroid composition and method for its preparation
Jan, 2025

(1 year, 11 months from now)

US7378405 BAUSCH Stabilized steroid composition and method for its preparation
Dec, 2026

(3 years from now)

Drugs and Companies using HYDROCORTISONE BUTYRATE ingredient

Market Authorisation Date: 18 May, 2007

Treatment: NA

Dosage: LOTION;TOPICAL

How can I launch a generic of LOCOID before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in